A chimeric monoclonal antibody directed against a primate-restricted N-linked carbohydrate epitope (glycotope) expressed on various human carcinomas with … [Read more...]
Search Results for: T
PI3K / mTOR kinase inhibitor PF-04691502
An agent targeting the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in the PI3K/mTOR signaling pathway, with potential … [Read more...]
Polo-like kinase 1 inhibitor ON 01910.Na
A synthetic benzyl styryl sulfone analogue with potential antineoplastic activity. Polo-like kinase 1 inhibitor ON 01910.Na inhibits polo-like kinase1 (Plk1), … [Read more...]
progesterone vaginal insert
A tablet preparation formulated for vaginal administration containing a micronized synthetic form of the endogenous steroid hormone progesterone with … [Read more...]
pan HER / VEGFR2 receptor tyrosine kinase inhibitor BMS-690154
A pyrrolotriazine-based compound and a pan inhibitor of receptor tyrosine kinases with potential antineoplastic activity. Pan HER/VEGFR2 receptor tyrosine … [Read more...]
Orathecin
(Other name for: rubitecan) … [Read more...]
Polo-like kinase 1 inhibitor GSK-461364
A small molecule Polo-like kinase 1 (PLK1) inhibitor with potential antineoplastic activity. Polo-like kinase 1 inhibitor GSK461364 selectively inhibits Plk1, … [Read more...]
multi-epitope melanoma peptide vaccine
A peptide cancer vaccine consisting of a combination of peptides derived form several melanoma epitopes. Vaccination with multi-epitope melanoma peptide vaccine … [Read more...]
Polo-like kinase 1 inhibitor BI 6727
A dihydropteridinone Polo-like kinase 1 (Plk1) inhibitor with potential antineoplastic activity. Polo-like kinase 1 inhibitor BI 6727 selectively inhibits Plk1, … [Read more...]
naltrexone hydrochloride
The hydrochloride salt of naltrexone, a noroxymorphone derivative with competitive opioid antagonistic activity. Naltrexone and its metabolite 6-beta-naltrexol … [Read more...]